We retrospectively reviewed patients with bacteremia treated with daptomycin. All 11 isolates were initially susceptible to daptomycin, but the emergence of daptomycin nonsusceptibility during treatment and clinical failure occurred in 36% and 45% of patients, respectively.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11528474 | PMC |
http://dx.doi.org/10.1093/ofid/ofae610 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!